Teva Pharmaceutical Industries reported $235M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Aspen Pharmacare ZAR 3.76B 1.04B Dec/2025
Cipla INR 10.43B 1.55B Sep/2026
Dr.Reddys Laboratories INR 12.16B 8.91B Sep/2026
Guangzhou Baiy CNY 565.01M 135.9M Sep/2026
Jiangsu Hengrui CNY 2.85B 1.17B Sep/2026
Kalbe Farma IDR 1.32T 466B Mar/2026
Richter Gedeon HUF 62.32B 1.26B Mar/2026
Sh Fosun Pharma CNY 863.03M 301.08M Sep/2026
Sun Pharmaceuticals INR 35.57B 8.05B Jun/2026
Teva Pharmaceutical Industries USD 235M 523M Jun/2026